Egyptian Drug Authority · Egypt
DEA-EG-2026-0034
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(34) For 2026
- Date issued
- Apr 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Dexamethasone -INAD PHARMA Solution for injection/infusion 8 mg\2ml
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Dexamethasone - INAD PHARMA
Solution for injection/infusion 8 mg\2ml
1587-
1589 1449 1476 1451 1571رقمالتشغيلة
12\2025-
12\2027
04\2025-
04\2027
05\2025-
05\2027
04\2025 -
04\2027
11/2025 –
11/2027
شركةإينادفارما
طبقا لإفادة شركة إينادفارما -صاحبة المستحضر
حيث افادت ان العبوات التي تحمل الاختلافات
الموضحة بعاليهلا تخصها و لميتم تصنيعها
بمعرفتها
وقف تداول و ضبط وتحريز المستحضر المقلد
في حالة الشك في المستحضر الصيدلىيتم الرجوع
الى هيئة الدواء المصرية سواء بالإتصالبالخط
الساخن 15301او الموقعالإلكترونىالخاص
بالهيئة.
يمكن الضغط على الرابطللإطلاععلى الصور
الخاصة بالمستحضر الغير مطابق للمواصفات .
أبريل 2026
منشور
غش تجاري
اسم المستحضر
تاريخ الإنتاج والانتهاء
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكين
هذا التنبيه خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق
على تداول المستحضر بشكل عام
الشركة المصنعةOriginal language: ar
- Notice text in English
- Notice. Dexamethasone solution for injection or infusion 8 mg/2ml, of Inad Pharma, batch numbers 1587, 1589, 1449, 1476, 1451 and 1571, with manufacturing and expiry dates running from 04/2025 to 12/2027. Issued on a report from Inad Pharma.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 3
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 567732dee7bc806e37933621ad4e81138d4ecf70d558d0054d0701a4192bab85SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:49:32 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0034: Dexamethasone -INAD PHARMA Solution for injection/infusion 8 mg\2ml — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0034Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.